The HeartStart FR2+ Defibrillator has come to be a trusted tool of
professional responders and designated response teams in the workplace and
public settings. Its clean, uncluttered design is optimized for fast,
efficient operation and rapid delivery of life-saving therapy. Commands are
clear, streamlined, confident, and concise: ideal for responders who are
trained, drilled, and ready to save a life now.
The therapy delivered by the HeartStart FR2+ is the most proven in the
industry. More than 40 studies confirm its effectiveness. Philips’
high-current/low energy therapy ensures a potent defibrillation dose, while
at the same time, minimizing side effects that may be harmful to a fragile
heart. So the HeartStart FR2+ can deliver its most powerful therapy from the
very first shock. There’s no need to hold back.
Capabilities and Features:
- Automated defibrillation, with manual override
(ECG model only)
- SMART Analysis
- SMART CPR and Quick Shock
- Infant/child defibrillation
- Conscious monitoring with optional FR2+ ECG
Assessment Module
- Optional rechargeable battery
- Two display options: text-only, and text with
ECG
- Voice and text prompts
- Over 8 hours of data collection
- Programmable voice recording
- Automated self-tests
- "Ready-for-Use" indicator
- Long-life battery: 300 shocks (minimum) or 12
hours monitoring
- Pads can connect to most ALS
defibrillator/monitors via pads adapters
- SMART CPR
Research shows that for some patients, especially those in long-duration
cardiac arrest, CPR prior to defibrillation may provide more benefit.1,2
The SMART CPR algorithm of the HeartStart FR2+ Defibrillator can be
configured to look at characteristics of a shockable heart rhythm and
advise the user to provide either an immediate defibrillation shock or
CPR first, followed by a shock.
- Quick Shock
Research also suggests that the opportunity for survival can be
improved if interruptions to CPR are minimized.3,4
The Quick Shock capability of the HeartStart FR2+ Defibrillator readies
the defibrillator within seconds to deliver a shock, reducing the time
between CPR and defibrillation.
1. Cobb LA, et al. JAMA. 1999; 281(13):1182-1188
2. Wik L, et al. JAMA. 2003 Mar 19; 289(11):1389-1395
3. Yu T, et al. Circulation. 2002; 106:368-372
4. Eftestol T, et al. Circulation. 2002;105:2270-2273
